BIOMAT Database Logo BIOMAT Database Logo

Maternal serum screening for Down's syndrome in early pregnancy. 1988

N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Department of Environmental and Preventive Medicine, Medical College of St. Bartholomew's Hospital, London.

The possibility of improving the effectiveness of antenatal screening for Down's syndrome by measuring human chorionic gonadotrophin concentrations in maternal serum during the second trimester to select women for diagnostic amniocentesis was examined. The median maternal serum human chorionic gonadotrophin concentration in 77 pregnancies associated with Down's syndrome was twice the median concentration in 385 unaffected pregnancies matched for maternal age, gestational age, and duration of storage of the serum sample. Measuring human chorionic gonadotrophin in maternal serum was an effective screening test, giving a lower false positive rate (3%) at a 30% detection rate than that for maternal age (5%) and the two existing serum screening tests, unconjugated oestriol (7%) and alpha fetoprotein (11%). The most effective screening results were obtained with all four variables combined; at the same 30% detection rate the false positive rate declined to 0.5%. The new screening method would detect over 60% of affected pregnancies, more than double that achievable with the same amniocentesis rate in existing programmes (5%), and could reduce the number of children born with Down's syndrome in the United Kingdom from about 900 a year to about 350 a year.

UI MeSH Term Description Entries
D008423 Maternal Age The age of the mother in PREGNANCY. Age, Maternal,Ages, Maternal,Maternal Ages
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D004964 Estriol A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, a large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol. (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,(16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol,16-alpha-Hydroxy-Estradiol,16alpha,17beta-Estriol,16beta-Hydroxy-Estradiol,Epiestriol,Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol,Ovestin,16 alpha Hydroxy Estradiol,16alpha,17beta Estriol,16beta Hydroxy Estradiol
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins

Related Publications

N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
[Maternal serum screening for Down's syndrome].
January 2002, Annales de biologie clinique,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Maternal serum screening policy for Down's syndrome.
September 1992, Lancet (London, England),
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Maternal serum screening for Down's syndrome in the first trimester of pregnancy.
August 1995, British journal of obstetrics and gynaecology,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
[Screening by maternal serum markers for Down's syndrome].
April 2003, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
August 1987, The New England journal of medicine,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Maternal serum AFP as screening test for Down's syndrome.
May 1984, Lancet (London, England),
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Maternal serum screening for Down's syndrome on population basis.
October 1997, Acta obstetricia et gynecologica Scandinavica,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Down's syndrome and maternal smoking in early pregnancy.
January 1997, Genetic epidemiology,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Maternal serum screening for Down's syndrome taking account of the result in a previous pregnancy.
April 1994, Prenatal diagnosis,
N J Wald, and H S Cuckle, and J W Densem, and K Nanchahal, and P Royston, and T Chard, and J E Haddow, and G J Knight, and G E Palomaki, and J A Canick
Maternal serum alpha-fetoprotein screening and Down's syndrome.
January 1988, American journal of obstetrics and gynecology,
Copied contents to your clipboard!